Literature DB >> 8656229

High uric acid: a metabolic marker of coronary heart disease among alcohol abstainers.

C Iribarren1, D S Sharp, J D Curb, K Yano.   

Abstract

The association between serum uric acid level and risk of coronary heart disease (CHD) over 21 years was investigated among 6411 middle-aged Japanese-American men who were participants in the Honolulu Heart Program. In an age-stratified Cox regression model, high serum uric acid (quartile 4 [>6.7 mg/dl], relative to quartile 1 [<5.0 mg/dl]) was a significant predictor of definite CHD (RR = 1.33; 95% confidence interval = 1.08-1.63; p = 0.006). However, when adjustment for confounders (body mass index, heavy alcohol consumption, triglycerides, diastolic blood pressure, blood glucose, and the ratio of animal to vegetable protein) was made, the association of high uric acid with coronary events was substantially reduced and became nonsignificant (RR = 1.14; 95% confidence interval = 0.92-1.42; p = 0.21). There was a significant interaction between serum uric acid and drinking status (P = 0.03). Thus, the risk of definite CHD associated with high urate levels (quartile 4), relative to low levels (quartile 1), was elevated in the abstainers (RR = 1.40; 95% confidence interval = 1.01-1.93; p = 0.02), but not in light and moderate drinkers (RR = 1.1 1; 95% confidence interval = 0.79-1.55; p = 0.58) or among the heavy drinkers (>40 ml of ethanol/day; RR = 0.57; 95% confidence interval = 0.27-1.21; p = 0.08). It is concluded that elevated uric acid may be associated with higher CHD among alcohol abstainers. Whether raised urate is an etiological factor for CHD or a manifestation of existing arterial disease in nondrinkers deserves further investigation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8656229     DOI: 10.1016/0895-4356(96)00034-0

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  9 in total

Review 1.  Serum uric acid is not an independent risk factor for coronary heart disease.

Authors:  S G Wannamethee
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 2.  Hyperuricemia and renal function.

Authors:  L M Ruilope; J Garcia-Puig
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

3.  Serum urate and the risk of major coronary heart disease events.

Authors:  S G Wannamethee; A G Shaper; P H Whincup
Journal:  Heart       Date:  1997-08       Impact factor: 5.994

4.  Relationship between hyperuricemia and other cardiovascular disease risk factors among adult males in Taiwan.

Authors:  N F Chu; D J Wang; S H Liou; S M Shieh
Journal:  Eur J Epidemiol       Date:  2000-01       Impact factor: 8.082

Review 5.  Hyperuricemia and coronary heart disease: a systematic review and meta-analysis.

Authors:  Seo Young Kim; James P Guevara; Kyoung Mi Kim; Hyon K Choi; Daniel F Heitjan; Daniel A Albert
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-02       Impact factor: 4.794

6.  Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout.

Authors:  F Cardona; F J Tinahones; E Collantes; A Escudero; E García-Fuentes; F J Soriguer
Journal:  Ann Rheum Dis       Date:  2004-04-28       Impact factor: 19.103

7.  Uric Acid and Coronary Artery Disease, Two Sides of a Single Coin: A Determinant of Antioxidant System or a Factor in Metabolic Syndrome.

Authors:  Babak Bagheri; Mehryar Zargari; Fatemeh Meshkini; Kolsoum Dinarvand; Vahid Mokhberi; Soheil Azizi; Mehdi Rasouli
Journal:  J Clin Diagn Res       Date:  2016-02-01

8.  Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis.

Authors:  Jeremy G Wheeler; Kelsey D M Juzwishin; Gudny Eiriksdottir; Vilmundur Gudnason; John Danesh
Journal:  PLoS Med       Date:  2005-03-29       Impact factor: 11.069

9.  Interaction between body mass index and serum uric acid in relation to blood pressure in community-dwelling Japanese men.

Authors:  Ryuichi Kawamoto; Daisuke Ninomiya; Kensuke Senzaki; Teru Kumagi
Journal:  Clin Hypertens       Date:  2018-01-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.